Cargando…
Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience
BACKGROUND: Autologous stem cell transplantation (autoSCT) can extend remission of mantle cell lymphoma (MCL), but the management of subsequent relapse is challenging. METHODS: We examined consecutive patients with MCL who underwent autoSCT at Veterans Affairs Puget Sound Health Care System between...
Autores principales: | Wu, Aaron, Graf, Solomon A., Burwick, Nicholas, Grim, Jonathan E., Dong, Zhao Ming, Richard, Robert E., Chauncey, Thomas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106113/ https://www.ncbi.nlm.nih.gov/pubmed/32269976 http://dx.doi.org/10.5045/br.2020.55.1.57 |
Ejemplares similares
-
Targeted Drugs as Maintenance Therapy after Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma
por: Yan, Fengting, et al.
Publicado: (2017) -
Autologous hematopoietic transplantation following COVID‐19 infection
por: Brzycki, Marthilde, et al.
Publicado: (2021) -
Autologous stem cell transplantation for mantle cell lymphoma – single centre experience
por: Szcześniak, Magdalena, et al.
Publicado: (2013) -
Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
por: Ekberg, Sara, et al.
Publicado: (2022) -
Assessing Cachexia Acutely after Autologous Stem Cell Transplant
por: Anderson, Lindsey J., et al.
Publicado: (2019)